companydata.dkPerfusion Tech ApS: Financial statements 2020
CVR: 38238213
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,092,073 and a net result of DKK -1,485,658 compared with DKK -596,373 the year before. Equity amounted to DKK -1,814,689. The company had 3 employees in the financial year.
- Gross Profit
- -1,092,073 kr.
- Profit/Loss
- -1,485,658 kr.
- Equity
- -1,814,689 kr.
- Total Assets
- 685,847 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -1.1 mio. | -1.5 mio. | -1.8 mio. | 3 |
| 2019 | - | -539 t. | -596 t. | -329 t. | 1 |
| 2018 | - | -262 t. | -238 t. | -453 t. | - |
| 2017 | - | -278 t. | -272 t. | -214 t. | - |
How creditworthy is Perfusion Tech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 8, 2020, Lars Henning Stigel has joined the board of directors of Perfusion Tech ApS.
As of December 8, 2020, Steffen Boutrup Møller has left the board of directors of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2019. Gross profit came to DKK -538,894, and the net result was DKK -596,373.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity amounted to DKK -9,640,655.